Terms: = Leukemia AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Treatment
20 results:
1. System analysis of surface CD markers during the process of granulocytic differentiation.
Novikova SE; Tolstova TV; Soloveva NA; Farafonova TE; Tikhonova OV; Kurbatov LK; Rusanov AL; Zgoda VG
Biomed Khim; 2023 Dec; 69(6):383-393. PubMed ID: 38153053
[TBL] [Abstract] [Full Text] [Related]
2. Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML).
Pohlmann A; Bentgens E; Schülke C; Kuron D; Reicherts C; Marx J; Angenendt L; Mikesch JH; Lenz G; Stelljes M; Schliemann C
Ann Hematol; 2023 Sep; 102(9):2543-2553. PubMed ID: 37428201
[TBL] [Abstract] [Full Text] [Related]
3. Nuclear Proteomics of Induced leukemia Cell Differentiation.
Novikova S; Tolstova T; Kurbatov L; Farafonova T; Tikhonova O; Soloveva N; Rusanov A; Archakov A; Zgoda V
Cells; 2022 Oct; 11(20):. PubMed ID: 36291090
[TBL] [Abstract] [Full Text] [Related]
4. Acute abdomen in the immunocompromised patient: WSES, sis-E, Wsis, AAST, and GAIS guidelines.
Coccolini F; Improta M; Sartelli M; Rasa K; Sawyer R; Coimbra R; Chiarugi M; Litvin A; Hardcastle T; Forfori F; Vincent JL; Hecker A; Ten Broek R; Bonavina L; Chirica M; Boggi U; Pikoulis E; Di Saverio S; Montravers P; Augustin G; Tartaglia D; Cicuttin E; Cremonini C; Viaggi B; De Simone B; Malbrain M; Shelat VG; Fugazzola P; Ansaloni L; Isik A; Rubio I; Kamal I; Corradi F; Tarasconi A; Gitto S; Podda M; Pikoulis A; Leppaniemi A; Ceresoli M; Romeo O; Moore EE; Demetrashvili Z; Biffl WL; Wani I; Tolonen M; Duane T; Dhingra S; DeAngelis N; Tan E; Abu-Zidan F; Ordonez C; Cui Y; Labricciosa F; Perrone G; Di Marzo F; Peitzman A; Sakakushev B; Sugrue M; Boermeester M; Nunez RM; Gomes CA; Bala M; Kluger Y; Catena F
World J Emerg Surg; 2021 Aug; 16(1):40. PubMed ID: 34372902
[TBL] [Abstract] [Full Text] [Related]
5. Gold Nanorods are Selective Cytotoxic Agents.
El Gendy M; Weinfeld M; Abdoon A
Anticancer Agents Med Chem; 2022; 22(5):991-998. PubMed ID: 34315395
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical Analysis of Driver Mutations in Patients with Ph Negative Myeloproliferative Neoplasms].
He ZP; Tian HY; Tan M; Wu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):842-848. PubMed ID: 29950230
[TBL] [Abstract] [Full Text] [Related]
7. Application of selected reaction monitoring and parallel reaction monitoring for investigation of HL-60 cell line differentiation.
Novikova SE; Tikhonova OV; Kurbatov LK; Farafonova TE; Vakhrushev IV; Zgoda VG
Eur J Mass Spectrom (Chichester); 2017 Aug; 23(4):202-208. PubMed ID: 29028392
[TBL] [Abstract] [Full Text] [Related]
8. Clinical presentation and risk factors of serious infections in children with Down syndrome treated for acute lymphoblastic leukemia.
Ceppi F; Stephens D; den Hollander BS; Krueger J; Whitlock J; Sung L; Hitzler J
Pediatr Blood Cancer; 2016 Nov; 63(11):1949-53. PubMed ID: 27399585
[TBL] [Abstract] [Full Text] [Related]
9. Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes.
Parikh SA; Rabe KG; Kay NE; Call TG; Ding W; Schwager SM; Bowen DA; Conte M; Jelinek DF; Slager SL; Shanafelt TD
Haematologica; 2014 Jan; 99(1):140-7. PubMed ID: 23911703
[TBL] [Abstract] [Full Text] [Related]
10. Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression.
Wågsäter D; Zhu C; Björck HM; Eriksson P
Atherosclerosis; 2009 Feb; 202(2):415-23. PubMed ID: 18573494
[TBL] [Abstract] [Full Text] [Related]
11. The development and application of imatinib.
Jones RL; Judson IR
Expert Opin Drug Saf; 2005 Mar; 4(2):183-91. PubMed ID: 15794712
[TBL] [Abstract] [Full Text] [Related]
12. c-sis/platelet-derived growth factor-B promoter requirements for induction during the 12-O-tetradecanoylphorbol-13-acetate-mediated megakaryoblastic differentiation of K562 human erythroleukemia cells.
Kujoth GC; Fahl WE
Cell Growth Differ; 1997 Sep; 8(9):963-77. PubMed ID: 9300179
[TBL] [Abstract] [Full Text] [Related]
13. treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
[TBL] [Abstract] [Full Text] [Related]
14. Identification and characterization of an essential, activating regulatory element of the human sis/pdgfb promoter in human megakaryocytes.
Jin HM; Brady ML; Fahl WE
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7563-7. PubMed ID: 8356057
[TBL] [Abstract] [Full Text] [Related]
15. [Human oncogene expression in the normal state and in various blood system diseases].
Ostrovskiĭ AM; Prianishnikov VA; Afanas'ev BV; Balaian LN
Ter Arkh; 1989; 61(7):11-3. PubMed ID: 2479991
[TBL] [Abstract] [Full Text] [Related]
16. Induction of platelet-derived growth factor gene expression during megakaryoblastic and monocytic differentiation of human leukemia cell lines.
Alitalo R; Andersson LC; Betsholtz C; Nilsson K; Westermark B; Heldin CH; Alitalo K
EMBO J; 1987 May; 6(5):1213-8. PubMed ID: 3475202
[TBL] [Abstract] [Full Text] [Related]
17. Effects of interferon-gamma on proto-oncogene expression during induction of human monocytic differentiation.
Sariban E; Mitchell T; Griffin J; Kufe DW
J Immunol; 1987 Mar; 138(6):1954-8. PubMed ID: 3102606
[TBL] [Abstract] [Full Text] [Related]
18. Platelet-derived growth factor. Phorbol ester induces the expression of the B-chain but not of the A-chain in HEL cells.
Weich HA; Herbst D; Schairer HU; Hoppe J
FEBS Lett; 1987 Mar; 213(1):89-94. PubMed ID: 3470198
[TBL] [Abstract] [Full Text] [Related]
19. Mechanism of interaction between antineoplastic agents and natural differentiation factors in the induction of human leukemic cell maturation.
Honma Y; Honma C; Bloch A
Cancer Res; 1986 Dec; 46(12 Pt 1):6311-5. PubMed ID: 3465437
[TBL] [Abstract] [Full Text] [Related]
20. Phorbol ester induces c-sis gene transcription in stem cell line K-562.
Colamonici OR; Trepel JB; Vidal CA; Neckers LM
Mol Cell Biol; 1986 May; 6(5):1847-50. PubMed ID: 3466024
[TBL] [Abstract] [Full Text] [Related]
